Publications scientifiques des membres de la GSASA 2014

Les travaux scientifiques ci-dessous ont été publiés dans différents journeaux internalionaux par des membres de la GSASA. Le résumé d'un travail sera affiché en cliquant sur le titre correspondant.

2014-3

Prospective risk assessment and incident reporting for better pharmaceutical care at paediatric hospital discharge

Kaestli LZ, Cingria L, Fonzo-Christe C, Bonnabry P
Int J Clin Pharm 2014 doi : 10.1007/s11096-014-9977-y4

Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns

Fonzo-Christe C, Guignard B, Zaugg C, Coehlo A, Posfay-Barbe KM, Gervaix A, Desmeules J, Rollason V, Combescure C, Corbelli R, Rimensberger P, Pfister R, Bonnabry P.
Ther Drug Monit 2014 doi: 10.1097/FTD.0000000000000071

Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU

Pierre Voirol, Markoulina Berger-Gryllaki, André Pannatier, Philippe Eggimann, Farshid Sadeghipour
Eur J Hosp Pharm (2014) doi: 10.1136/ejhpharm-2014-000478

Effective treatment of invasive aspergillus fumigatus infection using combinations of topical and systemic antifungals in a severely burned patient

Anne Fournier, Olivier Pantet, Samia Guerid, Philippe Eggimann, Jean-Luc Pagani, Jean-Pierre Revelly, Philippe M. Hauser, Oscar Marchetti, Sara Fontanella, Igor Letovanec, François Ravat, Mette M. Berger, André Pannatier, Pierre Voirol, Yok-Ai Que
J Burn Care Res 2014 doi: 10.1097/BCR.0000000000000143

Impact of pharmaceutical care on self-administration of outpatient low-molecular-weight heparin therapy

Seraina Mengiardi, Dimitrios A. Tsakiris, Viviane Molnar, Urs Kohlhaas-Styk, Michael Mittag, Stephan Kraehenbuehl, Kurt E. Hersberger
Pharmacology & Pharmacy. 2014; 5:372-85 http://dx.doi.org/10.4236/pp.2014.54045

2014-2

Adverse Drug Event Nonrecognition in Emergency Departments: An Exploratory Study on Factors Related to Patients and Drugs

Roulet L, Ballereau F, Hardouin JB, Chiffoleau A, Potel G, Asseray N
J Emerg Med. 2014 doi : 10.1016/j.jemermed.2013.11.124

Establishing a pharmacy presence in the emergency department: opportunities and challenges in the French setting

Roulet L, Asseray N, Ballereau F
Int J Clin Pharm. 2014;36(3):471-5 doi : 10.1007/s11096-014-9934-9

Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft: Vergleich der Fachinformationen in Deutschland und der Schweiz mit dem aktuellen Wissensstand

U. Winterfeld, V. Gotta, L.E. Rothuizen, A. Panchaud, A.O. Rossetti T. Buclin
Nervenarzt 2014 doi: 10.1007/s00115-014-4091-x

Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique

Alice Panchaud, Etienne Weisskopf , Ursula Winterfeld, David Baud, Monia Guidi, Chin Bin Eap, Chantal Csajka et Nicolas Widmer
Thérapie, 2014 doi:10.2515/therapie/2014026

Nanomedicines: addressing the scientific and regulatory gap

Tinkle S, McNeil SE, Mühlebach S, Bawa R, Borchard G, Barenholz YC, Tamarkin L, Desai N.
Ann N Y Acad Sci. doi: 10.1111/nyas.12403

First Asia-Pacific educational workshop on non-biological complex drugs (NBCDs), Kuala Lumpur, Malaysia, 8 October 2013

Philip D Walson,Stefan Mühlebach, Beat Flühmann
Generics and Biosimilars Initiative doi: 10.5639/gabij.2014.0301.010

Different pharmaceutical products need similar terminology

Crommelin DJ, de Vlieger JS, Weinstein V, Mühlebach S, Shah VP, Schellekens H.
AAPS J. 2014 Jan;16(1):11-4 doi: 10.1208/s12248-013-9532-0

How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider

Schellekens H, Stegemann S, Weinstein V, de Vlieger JS, Flühmann B, Mühlebach S, Gaspar R, Shah VP, Crommelin DJ
AAPS J. 2014 Jan;16(1):15-21 doi: 10.1208/s12248-013-9533-z

Trace element monitoring in the ICU: quality and economic impact of a change in sampling practice

Gagnon Ghislaine, Voirol Pierre, Soguel Ludivine, Boulat Olivier, Berger Mette M
Clin Nutr. 2014 pii: S0261-5614(14)00120-4. doi: 10.1016/j.clnu.2014.04.012

Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide

Humbert-Delaloye, V., Berger-Gryllaki, M., Voirol, P., Testa, B., Pannatier, A.
Eur J Hosp Phar doi:10.1136/ejhpharm-2013-000431

2014-1

Development of ready-to-use cefuroxime syringes for use in ophtalmology

Sandrine Fleury-Souverain, Farshid Sadeghipour, Pascal Bonnabry
Eur J Hosp Pharm 2014; 21:34-38 DOI 10.1007/s11096-014-9977-y

A survey-based inventory of clinical decision support systems in computerised provider order entry in Swiss hospitals

Delphine Carli-Ghabarou, Hanna M Seidling, Pascal Bonnabry, Christian Lovis
Swiss Med Wkly 2013;143:w13894 doi: 10.4414/smw.2013.13894

Medication use in pregnancy: a cross-sectional, multinational web-based study

A Lupattelli, O Spigset, M J Twigg, K Zagorodnikova, A C Mårdby, M E Moretti, M Drozd, A Panchaud, K Hämeen-Anttila, A Rieutord, R Gjergja Juraski, M Odalovic, D Kennedy, G Rudolf, H Juch, A Passier, I Björnsdóttir, H Nordeng
BMJ Open 2014;4: e004365. doi:10.1136/ bmjopen-2013-004365

Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey

Chantal Csajka, Aurélie Jaquet, Ursula Winterfeld, Yvonne Meyer, Adrienne Einarson, Alice Panchaud
Swiss Medical Weekly 2014 doi:10.4414/smw.2014.13936